Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 14-Feb-24 8:12 PM View:  | Enanta Pharmaceuticals Inc (ENTA) | 12-Feb-24 | Grant | 3,680 | -- | -- | < 1% 370.69K to 374.38K | |
| 14-Feb-24 8:12 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 12-Feb-24 | Payment of Exercise | 1,080 | $12.41 | $13,402.80 | (< 1%) 374.38K to 373.3K | |
| 06-Dec-23 8:22 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 05-Dec-23 | Sale | 2,412 | $9.63 | $23,227.60 | (< 1%) 373.11K to 370.69K | |
| 05-Dec-23 9:15 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 01-Dec-23 | Payment of Exercise | 1,595 | $9.49 | $15,136.50 | (< 1%) 374.7K to 373.11K | |
| 17-Mar-23 6:37 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 15-Mar-23 | Option Exercise | 13,925 | $14.00 | $194,950.00 | 4% 374.7K to 388.63K | |
| 17-Mar-23 6:37 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 15-Mar-23 | Planned Option Sale | 13,925 | $44.45 | $618,960.00 | (4%) 388.63K to 374.7K | |
| 15-Feb-23 9:46 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 13-Feb-23 | Grant | 23,267 | -- | -- | 6% 359.19K to 382.45K | |
| 15-Feb-23 9:46 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 13-Feb-23 | Payment of Exercise | 7,752 | $52.77 | $409,073.00 | (2%) 382.45K to 374.7K | |
| 05-Dec-22 7:22 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 01-Dec-22 | Payment of Exercise | 1,055 | $44.33 | $46,768.20 | (< 1%) 360.24K to 359.19K | |
| 28-Nov-22 6:23 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 23-Nov-22 | Grant | 21,000 | -- | -- | 6% 339.24K to 360.24K | |
| 15-Feb-22 9:40 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 14-Feb-22 | Grant | 3,034 | -- | -- | < 1% 337.16K to 340.19K | |
| 15-Feb-22 9:40 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 14-Feb-22 | Payment of Exercise | 953 | $62.49 | $59,553.00 | (< 1%) 340.19K to 339.24K | |
| 03-Dec-21 6:42 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 01-Dec-21 | Payment of Exercise | 557 | $87.68 | $48,837.80 | (< 1%) 337.72K to 337.16K | 4% |
| 23-Nov-21 7:36 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 19-Nov-21 | Grant | 6,800 | -- | -- | 2% 330.92K to 337.72K | |
| 28-Jan-21 5:41 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 26-Jan-21 | Option Exercise | 13,693 | $12.68 | $173,576.00 | 4% 317.23K to 330.92K | |
| 16-Dec-20 6:27 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 15-Dec-20 | Payment of Exercise | 1,540 | $42.52 | $65,480.80 | (< 1%) 318.76K to 317.23K | < 1% |
| 16-Dec-20 6:27 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 15-Dec-20 | Option Exercise | 5,250 | -- | -- | 2% 313.51K to 318.76K | |
| 20-Nov-20 8:30 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 20-Nov-20 | Grant | 7,600 | -- | -- | 2% 305.92K to 313.51K | |
| 18-Feb-20 6:05 AM View: | Enanta Pharmaceuticals Inc (ENTA) | 12-Feb-20 | Grant | 3,412 | -- | -- | 1% 303.59K to 307.0K | |
| 18-Feb-20 6:05 AM View: | Enanta Pharmaceuticals Inc (ENTA) | 12-Feb-20 | Payment of Exercise | 1,089 | $52.76 | $57,455.60 | (< 1%) 307.0K to 305.92K | 20% |
| 06-Jan-20 6:19 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 16-Dec-19 | Payment of Exercise | 2,331 | $63.88 | $148,904.00 | (< 1%) 305.92K to 303.59K | 34% |
| 06-Jan-20 6:19 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 16-Dec-19 | Option Exercise | 5,250 | -- | -- | 2% 300.67K to 305.92K | |
| 04-Mar-19 6:14 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 01-Mar-19 | Market Sale (Planned) | 10,000 | $103.53 | $1,035,320.00 | (3%) 310.67K to 300.67K | 59% |
| 13-Feb-19 9:11 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 12-Feb-19 | Grant | 15,750 | -- | -- | 5% 308.21K to 323.96K | |
| 13-Feb-19 9:11 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 12-Feb-19 | Payment of Exercise | 6,993 | $88.88 | $621,538.00 | (2%) 323.96K to 316.97K | 52% |
| 13-Feb-19 9:11 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 12-Feb-19 | Market Sale (Planned) | 6,297 | $90.07 | $567,173.00 | (2%) 316.97K to 310.67K | 53% |
| 13-Feb-19 9:11 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 11-Feb-19 | Option Exercise | 25,977 | $13.18 | $342,402.00 | 8% 309.92K to 335.9K | |
| 13-Feb-19 9:11 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 11-Feb-19 | Market Option Sale (Planned) | 25,977 | $89.39 | $2,322,140.00 | (8%) 335.9K to 309.92K | 53% |
| 13-Feb-19 9:11 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 11-Feb-19 | Market Sale (Planned) | 1,707 | $89.39 | $152,593.00 | (< 1%) 309.92K to 308.21K | 53% |
| 13-Feb-18 6:26 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 12-Feb-18 | Grant | 8,869 | -- | -- | 3% 303.72K to 312.59K | |
| 13-Feb-18 6:26 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 12-Feb-18 | Payment of Exercise | 2,666 | $76.85 | $204,869.00 | (< 1%) 312.59K to 309.92K | 45% |
| 15-Feb-17 5:46 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 13-Feb-17 | Grant | 2,920 | -- | -- | < 1% 301.88K to 304.8K | |
| 15-Feb-17 5:46 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 13-Feb-17 | Payment of Exercise | 1,079 | $29.82 | $32,170.40 | (< 1%) 304.8K to 303.72K | (42%) |
| 05-Jan-17 4:06 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 04-Jan-17 | Market Sale (Planned) | 13,921 | $35.09 | $488,505.00 | (4%) 315.8K to 301.88K | (21%) |
| 30-Nov-16 4:59 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 29-Nov-16 | Market Sale | 13,921 | $31.44 | $437,609.00 | (4%) 329.72K to 315.8K | (29%) |
| 20-Jan-16 4:09 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 19-Jan-16 | Option Exercise | 42,922 | $2.54 | $109,146.00 | 15% 286.8K to 329.72K | |
| 05-Jan-16 6:13 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 04-Jan-16 | Option Exercise | 78,565 | $2.54 | $199,445.00 | 38% 208.23K to 286.8K | |
| 11-Aug-15 4:11 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 10-Aug-15 | Market Sale (Planned) | 3,750 | $42.90 | $160,884.00 | (2%) 211.98K to 208.23K | 8% |
| 14-Jul-15 4:17 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 13-Jul-15 | Market Sale (Planned) | 3,750 | $46.29 | $173,594.00 | (2%) 215.73K to 211.98K | 15% |
| 15-Jun-15 4:18 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 11-Jun-15 | Market Sale (Planned) | 3,750 | $42.47 | $159,265.00 | (2%) 219.48K to 215.73K | 7% |
| 08-Jun-15 4:26 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 05-Jun-15 | Market Sale (Planned) | 10,750 | $42.02 | $451,662.00 | (5%) 230.23K to 219.48K | 6% |
| 12-May-15 5:20 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 11-May-15 | Market Sale (Planned) | 8,000 | $36.13 | $289,045.00 | (3%) 238.23K to 230.23K | (9%) |
| 06-Jan-15 4:44 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 06-Jan-15 | Option Exercise | 58,004 | $1.21 | $69,999.20 | 32% 180.23K to 238.23K | |
| 15-Aug-14 4:12 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 13-Aug-14 | Market Sale (Planned) | 5,000 | $39.49 | $197,441.00 | (3%) 185.23K to 180.23K | 1% |
| 06-Aug-14 4:16 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 05-Aug-14 | Option Exercise | 11,149 | $1.29 | $14,415.70 | 6% 174.08K to 185.23K | |
| 03-Jul-14 3:01 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 01-Jul-14 | Market Sale (Planned) | 5,000 | $42.24 | $211,218.00 | (3%) 179.08K to 174.08K | 8% |
| 04-Jun-14 4:05 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 02-Jun-14 | Market Sale (Planned) | 5,000 | $37.56 | $187,821.00 | (3%) 184.08K to 179.08K | (4%) |
| 02-May-14 5:17 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 01-May-14 | Market Sale (Planned) | 5,000 | $36.98 | $184,914.00 | (3%) 189.08K to 184.08K | (5%) |
| 02-Apr-14 4:30 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 01-Apr-14 | Market Sale (Planned) | 10,000 | $39.16 | $391,622.00 | (5%) 199.08K to 189.08K | < 1% |
| 25-Mar-14 8:07 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 24-Mar-14 | Market Sale (Planned) | 10,000 | $39.34 | $393,352.00 | (5%) 209.08K to 199.08K | < 1% |